Verification evidence is still being completed.
Age Labs AS
Oslo, Norway
- Verified lead
- Andre Lovestam
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Epigenetic Diagnostics, DNA Methylation Biomarkers, and Early-Disease Detection
- Review cycle
- 24 April 2026
- Full address
- Gaustadalleen 23A, 0373 Oslo, Norway
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Age Labs news post confirming Andre Lovestam as Chief Executive Officer.
- Editorial note
- Oslo molecular diagnostics startup with named CEO, epigenetic biomarker focus, and a lead rheumatoid arthritis early-detection program.
Epigenetic Diagnostics, DNA Methylation Biomarkers, and Early-Disease Detection
Public CEO disclosure, Norway Health Tech member profile, Biomarker development pipeline
Oslo molecular diagnostics startup with named CEO, epigenetic biomarker focus, and a lead rheumatoid arthritis early-detection program.
Age Labs AS
Epigenetic Diagnostics, DNA Methylation Biomarkers, and Early-Disease Detection · Molecular diagnostics development
Oslo molecular diagnostics startup with named CEO, epigenetic biomarker focus, and a lead rheumatoid arthritis early-detection program.
- Lead
- Andre Lovestam (verified ↗)
- Address
- Gaustadalleen 23A, 0373 Oslo, Norway (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Molecular diagnostics development
- Capabilities
- DNA Methylation Biomarker Discovery · Machine-Learning Biobank Analytics · Early Rheumatoid Arthritis Diagnostic
- Founded
- 2021
- Headcount
- 1-10
- Company page (open ↗)
Andre Lovestam
Chief Executive Officer
Norway Health Tech member profile listing Age Labs at Gaustadalleen 23A, Oslo.
Open sourceMolecular diagnostics development
Oslo, Norway. Epigenetic Diagnostics, DNA Methylation Biomarkers, and Early-Disease Detection. Review completed on 24 Apr 2026.
Norwegian Medicines Agency and EU IVDR for future clinical diagnostic launches
Public CEO disclosure, Norway Health Tech member profile, Biomarker development pipeline
Epigenetic Diagnostics, DNA Methylation Biomarkers, and Early-Disease Detection
Oslo molecular diagnostics startup with named CEO, epigenetic biomarker focus, and a lead rheumatoid arthritis early-detection program.
Age Labs is an Oslo molecular diagnostics startup translating epigenetic biobank data into early-detection tests, with a named CEO, a rheumatoid arthritis lead program, and Norway Health Tech member recognition.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Age Labs AS located?
- Age Labs AS operates from Gaustadalleen 23A, 0373 Oslo, Norway, Oslo, Norway.
- Who runs Age Labs AS?
- Age Labs AS is led by Andre Lovestam, Chief Executive Officer. Verified 24 Apr 2026.
- What does Age Labs AS do?
- Oslo molecular diagnostics startup with named CEO, epigenetic biomarker focus, and a lead rheumatoid arthritis early-detection program. Core capabilities: DNA Methylation Biomarker Discovery, Machine-Learning Biobank Analytics, Early Rheumatoid Arthritis Diagnostic.
Related technical briefs
Briefs that name Oslo as a covered market or city.
